Plainsboro, N.J.-based Integra LifeSciences announced an expansion of its credit facility consisting of an expanded term loan.
Here are four things to know:
1. Integra's bank group is led by Bank of America.
2. The company's credit facility will increase from $1.5 billion to $2.2 billion and its existing $1 billion revolving line of credit will remain the same.
3. Integra plans to use $700 million of the loan and borrowings from its existing revolving facility to finance its purchase of Codman Neurosurgery from Johnson & Johnson.
4. The incremental term loan will be available once the Codman Neurosurgery acquisition is completed.
More articles on devices:
After Unveiling in MIT Lecture, Xenco Medical Founder Announces Launch of Virtual, Holographic System for Surgical Planning
Conmed EVP purchases 440 company shares — 5 insights
CyMedica Orthopedics enrolls 1st patient in clinical rehabilitation trial — 4 details